- Hidehisa Asada Vice President, Research and Development, Ezose Sciences Inc.
- Lee E. Babiss Chief Scientific Officer & Executive Vice President, PPD, Inc.
- Paul Bolno Co-Founder & CEO, Renaptys
- Graham R. Brazier Vice President & Head of Transactions, Strategic Transactions Group, Bristol-Myers Squibb Company
- David Briel Executive Director, Office of International Business Development/DCED, Pennsylvania
- James Dolan Vice President, Licensing & Business Development, Purdue Phama L.P.
- David P. Flores Co-Founder, President & CEO, BioCentury Publications Inc.
- John Gill Chief Executive Officer, TetraLogic Pharmaceuticals
- Judith Hills Vice President Corporate Business Development, Ipsen Biopharm Ltd
- Chizuko Koseki Founder & Director, transB Ltd
- Lynn D. Kramer Chief Clinical Officer and President, Neuroscience & General Medicine PCU, Eisai, Inc.
- Kiyoshi Kurokawa Professor & Science Advisor to the Cabinet of Japan, National Graduate Institute for Policy Studies
- Hahn-Jun Lee President, Focus Therapeutics, LLC
- Ginny Llobell Vice President, Defined Health
- Stephen Paul Mahinka Partner, Morgan, Lewis & Bockius LLP
- Joseph S. McCracken Vice President & Global Head, Business Development & Licensing (Retired), Roche
- Martina Molsbergen Chief Executive Officer, C14 Consulting Group
- Haru Morita Chairman, President and Chief Executive Officer, REGiMMUNECorporation
- Arlene M. Morris President & Chief Executive Officer, Syndax Pharmaceuticals, Inc.
- Hans Nagl Senior Director, Commercial Insight, Sunovion Pharmaceuticals, Inc.
- Schalon Newton Vice President, Strategic Marketing and Business Development, Santen Inc.
- Keiko Oishi Senior Managing Director, CMIC Co., Ltd.
- Wendy Pan Partner, O’Melveny & Meyer LLP
- Terence G. Porter Vice President, Search & Evaluation, Global Business Development, Takeda Pharmaceuticals International, Inc.
- Kathleen Shay Partner, Duane Morris LLP
- Shunsuke Sami Member of the Board, Executive Vice President and Corporate Officer, Anges-MG, Inc
- Scott Siegel Chief Operating Officer, Ezose Sciences Inc.
- Goro Takeda Venture Partner, Sofinnova Ventures
- Tamao Watanabe Head, Global Licensing and Business Development, Kyowa Hakko Kirin (“KHK”), Tokyo, Japan
Co-Chairs:
- Sara Jane Demy CEO, Demy-Colton Life Science Advisors
- James E. Foley Partner, Aqua Partners LLC